Evangelic Hospital Unna, University of Duisburg-Essen, Germany.
Curr Opin Neurol. 2013 Jun;26(3):276-81. doi: 10.1097/WCO.0b013e328360d596.
Medication-overuse headache (MOH) is a well described clinical entity. There is a growing body of knowledge on the epidemiology of MOH, risk factors, and treatment strategies.
The International Headache Society updated the classification criteria for MOH. Population-based studies provided an insight into the prevalence and peculiarities of MOH patients in eastern Europe and Asia. Large-scaled population-based longitudinal studies made it possible to analyze risk factors leading to the development of MOH. Imaging studies helped to better understand the pathophysiology of headache chronicity. New treatment strategies have been suggested.
MOH is a common headache disorder and a serious public health problem all over the world. Although the treatment regimen for MOH patients is straightforward and the outcomes are favorable, it is time now to move forward and establish a predictive model for early recognition of patients at high risk, to intervene early and avoid development of chronic headache.
药物过度使用性头痛（MOH）是一种已被充分描述的临床病症。目前，人们对 MOH 的流行病学、危险因素和治疗策略有了更多的了解。
国际头痛协会更新了 MOH 的分类标准。基于人群的研究深入了解了东欧和亚洲 MOH 患者的患病率和特点。大规模的基于人群的纵向研究使分析导致 MOH 发生的危险因素成为可能。影像学研究有助于更好地理解头痛慢性化的病理生理学。新的治疗策略已经被提出。
MOH 是一种常见的头痛疾病，也是全世界严重的公共卫生问题。尽管 MOH 患者的治疗方案简单明了，且疗效良好，但现在是时候向前迈进，建立一个预测模型，以便早期识别高危患者，尽早进行干预，避免慢性头痛的发生。
